How We Treat Hemolytic Anemia Due to Pyruvate Kinase Deficiency.

While mitapivat addresses the previously unmet needs of most patients with PK deficiency as the first and only disease-modifying medication to receive approval for this condition, not all patients with PK deficiency are amenable to treatment with mitapivat.